Biotech · Private company · New York, NY, US
atai Therapeutics, Inc.
Track this companyFree. Adds atai Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- VLS-01-203 BUPhase 2 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)PHASE2 · COMPLETED · started Dec 30, 2024ClinicalTrials.gov NCT06524830 · fetched Nov 12, 2026
NIH awards2
- Optimization and Development of Non-Hallucinogenic 5-HT2A/2C Agonists as Opioid Use Disorder TherapeuticsFiscal year 2026 · $2.7MNIH RePORTER 5UG3DA064403-02 · fetched Nov 12, 2026
- Optimization and Development of Non-Hallucinogenic 5-HT2A/2C Agonists as Opioid Use Disorder TherapeuticsFiscal year 2025 · $2.9MNIH RePORTER 1UG3DA064403-01 · fetched Nov 12, 2026